Table 4.
hAChE |
Inhibition of Aβ1–42 aggregation (%) |
||
---|---|---|---|
Compd. | IC50 (μM)a | AChE-inducedb | Self-inducedc |
4c | 0.16 ± 0.02 | 29.02 ± 2.06 | 30.67 ± 6.54 |
4d | 0.57 ± 0.01 | 24.11 ± 3.04 | 26.01 ± 3.01 |
4e | 0.38 ± 0.02 | 20.28 ± 2.21 | 25.82 ± 1.43 |
4f | 1.21 ± 0.33 | 12.06 ± 3.18 | 20.35 ± 3.22 |
9a | 0.76 ± 0.10 | 14.19 ± 2.85 | 33.36 ± 4.85 |
9b | 0.39 ± 0.01 | 24.37 ± 3.03 | 35.29 ± 2.17 |
Donepezil | 0.021 ± 0.001 | 26.16 ± 2.55 | – |
Tacrine | 0.47 ± 0.03 | – | – |
Curcumin | – | – | 37.27 ± 2.76 |
aThe 50% inhibitory concentration of hAChE (means ± SD of three experiments).
bInhibition of AChE-induced Aβ1–42 aggregation. The thioflavin-T fluorescence method was used, and the concentration of the tested inhibitor was 100 μM (means ± SD of three experiments).
cInhibition of self-induced Aβ1-42 aggregation. The thioflavin-T fluorescence method was used, and the measurements were carried out in the presence of 25 μM inhibitor (means ± SD of three experiments).